Canna~Fangled Abstracts Cannabis therapy in rheumatological diseases: A systematic review As a library, NLM provides access to scientific literature. Inclusion in an NLM database does…Freedom WaresJuly 22, 2024
Canna~Fangled Abstracts Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review Review Exp Dermatol. 2024 Mar;33(3):e15064. doi: 10.1111/exd.15064. Ai Kuzumi 1, Takashi Yamashita 1, Takemichi Fukasawa 1 2, Asako Yoshizaki-Ogawa 1, Shinichi Sato 1, Ayumi Yoshizaki 1 2 Affiliations expand…Freedom WaresMarch 27, 2024
Canna~Fangled Abstracts Topical Cannabidiol in the Treatment of Digital Ulcers in Patients with Scleroderma: Comparative Analysis and Literature Review Journal List Lippincott Williams & Wilkins Open Access PMC9788924 Advances in Skin & Wound Care…Freedom WaresDecember 14, 2022
Canna~Fangled Abstracts Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases Journal List Cells v.11(24); 2022 Dec PMC9777118 Cells. 2022 Dec; 11(24): 4102. Published online 2022 Dec…Freedom WaresDecember 11, 2022
Canna~Fangled Abstracts Cannabidiol markedly alleviates skin and liver fibrosis Journal List > Front Pharmacol > PMC9627610 Front Pharmacol. 2022; 13: 981817. Published online 2022 Oct…Freedom WaresOctober 19, 2022
Canna~Fangled Abstracts Cannabinoids for the Treatment of Dermatologic Conditions Journal List > JID Innov > v.2(2); 2022 Mar > PMC8841811 JID Innov. 2022 Mar; 2(2):…Freedom WaresFebruary 28, 2022
Canna~Fangled Abstracts Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis. Phytomedicine. 2019 Dec 26;67:153160. doi: 10.1016/j.phymed.2019.153160. Jiang X1, Chen S2, Zhang Q2, Yi C2, He…Freedom WaresDecember 26, 2019
Canna~Fangled Abstracts Cannabinoids in the treatment of rheumatic diseases: Pros and cons. Autoimmun Rev. 2019 Oct 21:102409. doi: 10.1016/j.autrev.2019.102409. Sarzi-Puttini P1, Ablin J2, Trabelsi A2, Fitzcharles MA3,…Freedom WaresOctober 21, 2019
Canna~Fangled Abstracts Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for Systemic Sclerosis. Biochem Pharmacol. 2019 Feb 27. pii: S0006-2952(19)30077-2. doi: 10.1016/j.bcp.2019.02.029. García-Martín A1, Garrido-Rodríguez M2, Navarrete C3,…Freedom WaresFebruary 27, 2019
Canna~Fangled Abstracts VCE-004.3, A CANNABIDIOL AMINOQUINONE DERIVATIVE, PREVENTS BLEOMYCIN-INDUCED SKIN FIBROSIS AND INFLAMMATION TROUGH PPARγ- AND CB2 -DEPENDENT PATHWAYS. Br J Pharmacol. 2018 Jul 22. doi: 10.1111/bph.14450. Del Rio C1,2,3, Cantarero I1,2,3, Palomares B1,2,3,…Freedom WaresJuly 22, 2018